WASHINGTON, D.C., Sept. 1, 2020 – The American Psychiatric Association (APA) today released a new evidence-based practice guideline to enhance the treatment of patients with schizophrenia. Its goals are to reduce the mortality, morbidity and significant psychosocial and health consequences of this psychiatric condition.
An executive summary of the guideline is published in the American Journal of Psychiatry, available online today. The full guideline and related materials are available at psychiatry.org/psychiatrists/practice/clinical-practice-guidelines.
Schizophrenia is one of the top 20 causes of disability worldwide. The lifetime prevalence of...Read More